Related Experiment Video
Updated: Aug 2, 2026

06:33
Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
Alpha-thalassaemia: prevalence and pattern in northern Pakistan
1Haematology Department, Armed Forces Institute of Pathology, Rawalpindi.
JPMA. the Journal of the Pakistan Medical Association
|October 1, 1991
Summary
This study screened 500 cord blood samples in Pakistan for Hb Bart's, revealing a 2.4% prevalence of the alpha-thalassemia gene carrier state. This simple screening method helps understand gene prevalence in populations.
Area of Science:
- Genetics
- Hematology
- Public Health
Background:
- Alpha-thalassemia is a genetic blood disorder.
- Hb Bart's levels in cord blood indicate alpha-thalassemia gene inheritance.
- Population screening is crucial for understanding genetic disorder prevalence.
Purpose of the Study:
- To determine the prevalence of the alpha-thalassemia gene in northern Pakistan.
- To utilize Hb Bart's levels in cord blood as a screening tool.
- To identify carrier groups based on Hb Bart's concentration.
Main Methods:
- Analysis of 500 cord blood samples collected between 1986-1987.
- Quantification of Hemoglobin Bart's (Hb Bart's) concentration using electrophoresis.
- Categorization of samples into distinct groups based on Hb Bart's levels.
Main Results:
- Hb Bart's was detected in 12 neonates, indicating a 2.4% prevalence of alpha-thalassemia carriers.
- Two carrier groups were identified: 75% with 2.0-3.5% Hb Bart's (alpha-thalassemia-2) and 25% with 5.8-6.3% Hb Bart's (alpha-thalassemia-1).
- No cases of Hb H disease or Hb Bart's hydrops fetalis were observed.
Conclusions:
- Hb Bart's screening in cord blood is an effective method for estimating alpha-thalassemia gene prevalence.
- The study identified a 2.4% carrier rate for alpha-thalassemia in the studied population.
- Further research can guide public health strategies for managing thalassemia.
More Related Videos
Related Concept Videos
Alternative RNA Splicing
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Testing a Claim about Population Proportion
A complete procedure for testing a claim about a population proportion is provided here.
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...

